IDEXX Laboratories, Inc.IDXXNASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 59% recommend buying.

Consensus Rating

Buy

22 analysts·High coverage

59%

Rating Distribution

Strong Buy

00%

Buy

1359%

Hold

836%

Sell

15%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 23% higher.

Bear Case

$730.00

+15%

Consensus

$784.38

+23%

Bull Case

$830.00

+30%

Price Range22 analysts

Low

Consensus

High

$730.00

$830.00

Current Target

Current Price

$636.70

Upside to Target

$147.68

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$14.56(11 analysts)

P/E50x

Current: 49.6x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+8.66%

EPS+13.02%

FY2028

Rev+9.67%

EPS+13.95%

FY2029

Rev+10.47%

EPS+14.45%

Earnings Surprises

Beat rate:100%(12/12 quarters)

Avg surprise:+6.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 9, 2026Piper Sandler

Idexx Laboratories price target lowered to $750 from $775 at Piper Sandler

Target:$750.00

+16.3%from $644.61

Feb 5, 2026Barclays

Idexx Laboratories price target lowered to $800 from $850 at Barclays

Target:$800.00

+24.4%from $642.94

Feb 3, 2026UBS

Idexx Laboratories price target lowered to $730 from $750 at UBS

Target:$730.00

+14.1%from $639.60

Feb 3, 2026BTIG

Idexx Laboratories price target lowered to $800 from $830 at BTIG

Target:$800.00

+25.1%from $639.60

Dec 8, 2025Barclays

Idexx Laboratories initiated with an Overweight at Barclays

Target:$850.00

+20.3%from $706.65

Nov 4, 2025Morgan Stanley

Idexx Laboratories price target raised to $805 from $765 at Morgan Stanley

Target:$805.00

+11.6%from $721.04

Nov 4, 2025UBS

Idexx Laboratories price target raised to $750 from $710 at UBS

Target:$750.00

+3.7%from $722.94

Nov 4, 2025BTIG

Idexx Laboratories price target raised to $830 from $785 at BTIG

Target:$830.00

+14.8%from $722.94

Nov 4, 2025Jefferies

IDEXX Laboratories (IDXX) PT Raised to $830 at Jefferies

Target:$830.00

+14.8%from $722.94

Nov 3, 2025Leerink Partners

Idexx Laboratories price target raised to $785 from $745 at Leerink

Target:$785.00

+8.6%from $722.94

Nov 3, 2025Stifel Nicolaus

IDEXX Laboratories (IDXX) PT Raised to $775 at Stifel

Target:$775.00

+7.2%from $722.94

Oct 31, 2025Stifel Nicolaus

Stifel Upgrades IDEXX Laboratories (IDXX) to Buy

Target:$700.00

+11.4%from $628.54

Oct 1, 2025UBS

Idexx Laboratories initiated with a Neutral at UBS

Target:$720.00

+12.7%from $638.89

Aug 5, 2025Morgan Stanley

Idexx Laboratories price target raised to $722 from $626 at Morgan Stanley

Target:$722.00

+12.5%from $641.94

Aug 5, 2025BTIG

Idexx Laboratories price target raised to $785 from $545 at BTIG

Target:$785.00

+22.3%from $641.94

Aug 4, 2025Stifel Nicolaus

Idexx Laboratories price target raised to $640 from $540 at Stifel

Target:$640.00

-6.3%from $682.78

Jun 24, 2024Stifel Nicolaus

Idexx Laboratories price target lowered to $510 from $520 at Stifel

Target:$510.00

+2.9%from $495.73

Feb 8, 2023Barclays

Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $590

Target:$590.00

+16.2%from $507.68

Feb 7, 2023J.P. Morgan

JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $550

Target:$550.00

+12.9%from $487.04

Feb 7, 2023Atlantic Equities

Atlantic Equities Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600

Target:$600.00

+23.6%from $485.53

Feb 2, 2023Oppenheimer

Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $247

Target:$247.00

-48.9%from $483.20

Feb 2, 2023Citigroup

Citigroup Maintains Buy on IDEX, Lowers Price Target to $268

Target:$268.00

-44.5%from $483.20

Dec 9, 2022Citigroup

Citigroup Maintains Buy on IDEX, Raises Price Target to $273

Target:$273.00

-35.1%from $420.63

Nov 15, 2022Morgan Stanley

Morgan Stanley Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $543

Target:$543.00

+24.6%from $435.78

Jun 24, 2022Stifel Nicolaus

Stifel Maintains Buy on IDEXX Laboratories, Lowers Price Target to $500

Target:$500.00

+40.6%from $355.62

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance